Peptips is medical-adjacent. That means the way we write has to be more careful than a typical wellness site, and it means we have to show our work. This page is the short version. The full versioned spec lives at /methodology/v1-2.
Every claim about a drug, a dose, or a side effect links to the FDA prescribing information or to the published trial, never to a press release, never to a content marketer, never to another secondary source.
We say semaglutide (Ozempic, Wegovy), not just Ozempic. The molecule is the thing. The brand is the marketing.
Long-term data does not yet exist for most of this drug class. Where the literature is thin, we say so in the body of the post, not in a footnote.
We do not accept payment from drug manufacturers or from any of the cash-pay GLP-1 telehealth providers. Trust is the asset.
Trial readouts and label updates trigger a post refresh. Updated dates show on every post.
The Evidence Score is not a product rating. It is a confidence score for a specific claim, semaglutide preserves weight loss at 68 weeks, for instance. Five weighted dimensions go in, one number comes out, and the tier label tells you how much weight to put on it.
Posts that discuss a specific drug, dose, or protocol carry a check stamp at the top. Every dose, indication, and side-effect figure is verified against the current FDA prescribing information and the published trial before it ships, and the check date shows on the post. We do not claim review by a named outside clinician.